SuperGen, Inc. to Present at the Second Annual Piper Jaffray London Healthcare Conference

DUBLIN, Calif., June 14 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that Dr. James S. Manuso, President and CEO, will present a corporate overview and highlight SuperGen's recent developments at the Second Annual Piper Jaffray London Healthcare Conference at 10:40 a.m. BST on Thursday, June 21, 2007, at the Great Eastern Hotel in London.

A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the company's Web site at The Webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit

Contacts: SuperGen SuperGen Timothy L. Enns Mary M. Vegh S.V.P., Corporate Communications & Manager, Investor Relations Business Development (925) 560-2845 (925) 560-0100 x111

SuperGen Inc.

CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, +1-925-560-0100 X111,, or Mary M. VeghManager, Investor Relations, +1-925-560-2845, bothof SuperGen Inc.

Back to news